Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 2873 entries
View as:

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02600949 Org: User:
Start: 05/11/16 End: 05/31/25 Due: 05/31/26

Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction

Phase: N/A Priority: Normal
NCT ID: NCT03326570 Org: User:
Start: 08/25/11 End: 04/01/19 Due: 04/01/20

Tele-PancFit: A Multi-site Trial of Video-based Strengthening Exercise Prehabilitation for Patients With Resectable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05836870 Org: User:
Start: 07/18/23 End: 12/31/32 Due: 12/31/33

Brief Guided Relaxation for Women Undergoing Stereotactic Breast Biopsy

Phase: N/A Priority: Normal
NCT ID: NCT03023215 Org: User:
Start: 10/26/12 End: 08/10/22 Due: 08/10/23

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00801489 Org: User:
Start: 04/04/07 End: 10/11/28 Due: 10/11/29

Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02684227 Org: User:
Start: 08/24/16 End: 09/27/23 Due: 09/27/24

PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00866346 Org: User:
Start: 03/31/08 End: - Due: -

Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC)

Phase: N/A Priority: Normal
NCT ID: NCT02662608 Org: User:
Start: 12/29/15 End: 03/06/16 Due: 03/06/17

Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00043823 Org: User:
Start: 08/01/02 End: 05/15/06 Due: 05/15/07

ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin

Phase: N/A Priority: Normal
NCT ID: NCT00054691 Org: User:
Start: 05/31/04 End: 10/31/12 Due: 10/31/13

Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00607113 Org: User:
Start: 01/31/08 End: 10/31/11 Due: 10/31/12

Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics

Phase: N/A Priority: Normal
NCT ID: NCT01502150 Org: User:
Start: 06/16/05 End: 06/01/21 Due: 06/01/22

Male:Female Birth Ratios and Phthalate Levels

Phase: N/A Priority: Normal
NCT ID: NCT00903318 Org: User:
Start: 05/15/09 End: 02/09/17 Due: 02/09/18

Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Phase: N/A Priority: Normal
NCT ID: NCT00004142 Org: User:
Start: 08/05/98 End: 12/09/03 Due: 12/09/04

Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01505868 Org: User:
Start: 07/11/12 End: 12/09/19 Due: 12/09/20

Molecular Imaging for Detection of Cervical Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT00511615 Org: User:
Start: 03/31/05 End: 02/29/08 Due: 02/28/09

Perception of Palliative Care Encounter

Phase: N/A Priority: Normal
NCT ID: NCT02558257 Org: User:
Start: 08/16/15 End: 04/07/21 Due: 04/07/22

Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00495170 Org: User:
Start: 04/14/06 End: 06/14/17 Due: 06/14/18

Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01471106 Org: User:
Start: 01/21/14 End: 05/30/24 Due: 05/30/25

Physical Activity After Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00501761 Org: User:
Start: 05/31/05 End: 05/31/25 Due: 05/31/26

High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection

Phase: N/A Priority: Normal
NCT ID: NCT02095847 Org: User:
Start: - End: 03/31/15 Due: 03/31/16

A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT00493688 Org: User:
Start: 10/30/05 End: 10/30/25 Due: 10/30/26

Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood

Phase: N/A Priority: Normal
NCT ID: NCT01497184 Org: User:
Start: 12/31/11 End: 03/08/21 Due: 03/08/22

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT05011045 Org: User:
Start: 01/09/20 End: 10/31/26 Due: 10/31/27

Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04404088 Org: User:
Start: 07/16/20 End: 03/01/28 Due: 03/01/29